Peritonitis in peritoneal dialysis patients in Japan: A 2013 retrospective questionnaire survey of Japanese Society for Peritoneal Dialysis member institutions

被引:0
|
作者
Higuchi C. [1 ]
Ito M. [2 ]
Masakane I. [2 ]
Sakura H. [1 ]
机构
[1] Department of Medicine, Tokyo Women's Medical University Medical Center East, 2-1-10 Nishiogu Arakawa-ku, Tokyo
[2] Yabuki Hospital, 4-5-5 Shimakita, Yamagata City, Yamagata
关键词
Antibiotic administration methods; Catheter exit-site infection; Effluent culture technique; PD peritonitis incidence; Previous peritonitis episodes;
D O I
10.1186/s41100-016-0014-6
中图分类号
学科分类号
摘要
Background: Peritonitis is the main cause of withdrawal from peritoneal dialysis (PD) therapy in Japan. The precise extent of PD-associated peritonitis in Japan has not been investigated since 2005; we aimed to clarify the recent incidence and prognosis of PD peritonitis. Methods: The 248 institutional members of the Japanese Society for Peritoneal Dialysis were surveyed by questionnaire regarding peritonitis episodes during January 1 to December 31, 2013. Results: Replies from 114 members were received regarding 3042 PD patients, including 516 peritonitis patients, covering a total observation period of 31,686 patient months. The incidence of peritonitis in this study was 0.195 episodes per year. Detailed data on 544 peritonitis episodes in 466 patients was obtained. The causes, in ranked order, were unknown reason, contamination at peritoneal fluid exchange, and extension of intra-abdominal cavity infection. Effluent culture methods included using a blood culture bottle (50.9 %), large-volume culture (culturing sediment after centrifuging effluent) (31.7 %), and direct culture of effluent using a culture dish (12.7 %). The rank order of microbes identified in peritoneal effluent cultures was culture-negative, Streptococcus sp. and Staphylococcus aureus. Empiric therapy with two kinds of antibiotics was administered to 406 cases (75.2 %), most commonly cefazolin + ceftazidime. Antibiotic administration methods included intraperitoneal (51.4 %), intravenous (46.4 %), and oral (2.2 %). After a peritonitis episode, 461 patients (84.7 %) continued PD therapy, 80 (14.7 %) withdrew from PD treatment, and 6 (1.1 %) died. Prognosis among patients grouped by antibiotic administration method was statistically significantly different; in the oral administration group, the rates of mortality and catheter replacement were higher. Logistic regression analysis showed that catheter exit-site infection and frequency of past peritonitis episodes were independent factors associated with PD treatment withdrawal. Conclusions: Although the overall incidence of PD peritonitis in Japan was relatively low, several areas for future improvement were identified: Unknown reason and culture-negative were the most frequently cited causes of peritonitis; 1.1 % of patients died, and 13.6 % discontinued PD therapy. Improvements in effluent culture techniques, antibiotic administration methods, etiology determination, and patient education could help. A more effective protocol must be established to further improve the treatment of PD peritonitis in Japan. © 2016 The Author(s).
引用
收藏
相关论文
共 50 条
  • [41] MICROBIOLOGY OF PERITONITIS IN PERITONEAL DIALYSIS PATIENTS WITH MULTIPLE EPISODES
    Nessim, Sharon J.
    Nisenbaum, Rosane
    Bargman, Joanne M.
    Jassal, Sarbjit V.
    PERITONEAL DIALYSIS INTERNATIONAL, 2012, 32 (03): : 316 - 321
  • [42] FLAVOBACTERIAL PERITONITIS IN PATIENTS TREATED BY PERITONEAL-DIALYSIS
    KORZETS, Z
    MAAYAN, MC
    BERNHEIM, J
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1995, 10 (02) : 280 - 283
  • [43] Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis
    Bren, A
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1998, 17 (12) : 839 - 843
  • [44] Use of cefazolin for peritonitis treatment in peritoneal dialysis patients
    Agraharkar, M
    Klevjer-Anderson, P
    Rubinstien, E
    Galen, M
    AMERICAN JOURNAL OF NEPHROLOGY, 1999, 19 (05) : 555 - 558
  • [45] PERITONITIS IN PATIENTS ON CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
    GREFBERG, N
    DANIELSON, BG
    NILSSON, P
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1984, 16 (02) : 187 - 194
  • [46] Peritonitis due to Aspergillus tamarii in peritoneal dialysis patients
    Parinyasiri, Uraiwan
    Uppamai, Sriphrae
    Chamroensakchai, Tamonwan
    Sirinual, Sirirat
    Sukmee, Korawee
    Banjongjit, Athiphat
    Kanjanabuch, Talerngsak
    MEDICAL MYCOLOGY CASE REPORTS, 2023, 40 : 44 - 46
  • [47] MICROBIOLOGY AND OUTCOMES OF PERITONITIS IN AUSTRALIAN PERITONEAL DIALYSIS PATIENTS
    Ghali, Joanna R.
    Bannister, Kym M.
    Brown, Fiona G.
    Rosman, Johan B.
    Wiggins, Kathryn J.
    Johnson, David W.
    McDonald, Stephen P.
    PERITONEAL DIALYSIS INTERNATIONAL, 2011, 31 (06): : 651 - 662
  • [48] Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients
    Miles, Rhianna
    Hawley, Carmel M.
    McDonald, Stephen P.
    Brown, Fiona G.
    Rosman, Johan B.
    Wiggins, Kathryn J.
    Bannister, Kym M.
    Johnson, David W.
    KIDNEY INTERNATIONAL, 2009, 76 (06) : 622 - 628
  • [49] Gastroscopy-Related Peritonitis in Peritoneal Dialysis Patients
    Nadeau-Fredette, Annie-Claire
    Bargman, Joanne M.
    PERITONEAL DIALYSIS INTERNATIONAL, 2014, 34 (06): : 667 - U111
  • [50] The factors related to fungal peritonitis in patients on peritoneal dialysis
    Zhu Zhonghua
    Zhang Weizhuo
    Yang Xiao
    Luo Changqing
    Fu Ling
    Zhu Hongyan
    Current Medical Science, 1997, 17 (2) : 123 - 125